Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$511,776
+$115,404 QoQ
Shares Held
4,800
+98.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#400
of 663 holders
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Blueshift Asset Management, LLC holds $9,217,770 across 26 Biotechnology names. INSM ranks #6 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,843 | $1,149,184 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
30,383 | $1,075,254 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
2,834 | $693,678 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,118 | $637,581 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
4,209 | $558,660 | |
| 6 | INSM |
INSMED Inc
This page
|
4,800 | $511,776 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
8,143 | $465,942 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
4,819 | $392,796 |
All Filings in INSM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $511,776 | 4,800 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $396,372 | 2,424 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $464,338 | 2,668 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $304,005 | 2,111 | Shares | Sole | 2025-11-13 | |
| 2024-09-30 | $364,781 | 4,997 | Shares | Sole | 2024-11-13 | |
| 2021-12-31 | $243,934 | 8,955 | Shares | Sole | 2022-02-11 | |
| 2021-06-30 | $659,788 | 23,183 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $206,631 | 6,207 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||